Med BioGene Inc. completes acquisition of Dragon-Tex (Group) Limited and $2 million financing
Med BioGene Inc. announced that it completed its acquisition of Dragon-Tex (Group) Limited ("DTX"). As part of the acquisition, the shareholders of DTX exchanged their common shares for common shares of MBI on the basis of two common shares of DTX for one common share of MBI.
Furthermore, concurrently with the closing of the acquisition, MBI completed a brokered private placement for gross proceeds of approximately $2 million. MBI reported that the private placement was oversubscribed by 38%. Blackmont Capital Inc. was the agent for the private placement.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.